SCHEMBL9696756

SCHEMBL9696756

O=C(O)c1ccc(SCCl)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.52
TP53 P04637 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.50
ALOX15 P16050 1/20 0.48
SRD5A2 P31213 4/20 0.46
HTT P42858 1/20 0.46
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA12 O43570 1/20 0.44
CA3 P07451 1/20 0.44
TYR P14679 1/20 0.44
DRD1 P21728 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
CA5A P35218 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
CA5B Q9Y2D0 1/20 0.44
ALDH1A1 P00352 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2914385 0.83 TSHR (0.48) TSHRTP53SMN1; SMN2ALOX15SRD5A2
SCHEMBL9696719 0.83 ALDH1A1 (0.41) SMN1; SMN2CA1CA2ALDH1A1MEN1
SCHEMBL8179270 0.81 CA1 (0.43) SMN1; SMN2CA1CA2CA12CA3
SCHEMBL9695086 0.81 PARP10 (0.43) TSHRSMN1; SMN2CA1CA2ALDH1A1
SCHEMBL10876734 0.80 PLA2G4B (0.53) TSHRTP53SMN1; SMN2ALOX15HTT
SCHEMBL504032 0.78 HTT (0.55) TSHRTP53SMN1; SMN2ALOX15SRD5A2
SCHEMBL8179454 0.78 SMN1; SMN2 (0.33) SMN1; SMN2HTTALDH1A1MAPT
SCHEMBL5441804 0.78 FFAR1 (0.65) TSHRTP53SMN1; SMN2ALOX15SRD5A2
SCHEMBL9696902 0.78 MAPT (0.57) CA1CA2CA9ALDH1A1KDM4E
SCHEMBL1018288 0.77 CA2 (0.52) TSHRTP53SMN1; SMN2ALOX15SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0481511-A2 Antibiotic C-3 dithioacetal-substituted carbapenem compounds, compositions, and use thereof Bristol-Myers Squibb Company (US) 1992-04-22 EP disclosed